跳至主要内容
临床试验/IRCT2017092724081N3
IRCT2017092724081N3已完成2 期

The assesment of the effects of omega 3 faty acid supplementation on serum level of Omentin , Chemerin and TNF-alpha in patients with type 2 diabetes mellitus

Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 65 years(—)
性别
All

入选标准

  • The criteria for inclusion were as follows: 30-65 years of age; T2DM diagnosis; and BMI in the range of 18.5 to 40 kg/m2. Patients with a history of diseases including chronic renal; hepatic; gastrointestinal; hematological diseases; and thyroid disorder as well as pregnant and lactating patients were excluded from the study. Furthermore, Patients who were treated with insulin; Thiazolidinediones or consumed weight loss drugs and any nutritional supplement 2 weeks prior to the beginning of the study were excluded from the study.
  • The exclusion criteria: Unwillingness to cooperate; change the dose or type of anti-diabetes drug; incidence of any sensitivity Interventions.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran University of Medical Sciences

相似试验